secwatch.observer — SEC 8-K summary
======================================

Issuer:     Prelude Therapeutics Inc (PRLD)
CIK:        0001678660
Form:       8-K
Filed at:   2025-09-19T23:59:59+00:00
Accession:  0001193125-25-208187
Event type: other_material
Sentiment:  positive
Materiality: 0.50
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Prelude Therapeutics regains Nasdaq minimum bid price compliance as of Sept 18, 2025
--------------------------------------------------------------------------------

- Received Nasdaq non-compliance notice on March 27, 2025 for failing $1.00 bid price requirement.
- On September 18, 2025, Nasdaq confirmed compliance with Listing Rule 5550(a)(2) and closed the matter.
- Common stock (PRLD) remains listed on Nasdaq Global Select Market with bid price issue resolved.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1678660/000119312525208187/0001193125-25-208187-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1678660/000119312525208187/prld-20250918.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-208187

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer